av/celldex-therapeutics--big.svg

NASDAQ:CLDX

Celldex

  • Stock

USD

Last Close

23.26

06/11 21:01

Market Cap

2.41B

Beta: 2.11

Volume Today

599.89K

Avg: 647.39K

PE Ratio

−15.31

PFCF: −20.78

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-118.08M
-
-127.20M
7.72%
-128.53M
1.05%
-93.03M
27.62%
-151.18M
62.51%
-50.88M
66.35%
-59.78M
17.50%
-70.51M
17.95%
-112.33M
59.30%
-141.43M
25.91%
depreciation and amortization
3.40M
-
4.01M
17.94%
4.09M
2.02%
5.31M
29.77%
3.80M
28.42%
4.86M
27.81%
3.93M
19.12%
3.07M
21.91%
2.90M
5.61%
3.01M
3.87%
deferred income tax
90K
-
350K
288.89%
1.01M
187.71%
-24.28M
2,511.32%
-765K
96.85%
671K
187.71%
-1.17M
273.92%
-227K
80.55%
-227K
0%
-22.80M
9,945.37%
stock based compensation
6.85M
-
12.77M
86.43%
15.32M
19.91%
12.31M
19.62%
8.08M
34.36%
4.55M
43.68%
3.92M
13.97%
8.95M
128.68%
15.61M
74.37%
23.89M
53.03%
change in working capital
6.13M
-
10.89M
77.66%
-6.56M
160.26%
-12.21M
86.05%
-15.37M
25.95%
-4.32M
71.88%
-299K
93.08%
-1.05M
252.51%
-3.90M
269.83%
13.46M
445.36%
accounts receivables
62K
-
-814K
-
-96K
88.21%
-777K
709.38%
-777K
0%
-787K
1.29%
1.57M
300%
-175K
111.12%
-2.28M
1,203.43%
inventory
-687K
-
-3.57M
419.65%
1.78M
149.94%
13.89M
678.86%
accounts payables
-4.97M
-
-8.74M
75.94%
-13.11M
49.93%
-13.11M
0%
1.64M
112.49%
3.65M
123.02%
3.12M
14.51%
9.38M
200.48%
other working capital
6.07M
-
10.89M
79.48%
-89K
100.82%
205K
330.34%
-3.27M
1,694.15%
-4.32M
32.28%
-1.15M
73.40%
-6.28M
446.17%
-6.85M
9.00%
6.36M
192.89%
other non cash items
72K
-
288K
300%
1.64M
468.75%
11.96M
630.46%
80.20M
570.32%
-1.29M
101.61%
13.00M
1,104.48%
-1.14M
108.76%
-5.79M
408.70%
16.58M
386.42%
net cash provided by operating activities
-101.54M
-
-98.89M
2.61%
-113.04M
14.31%
-99.93M
11.59%
-75.23M
24.71%
-46.41M
38.31%
-40.40M
12.95%
-60.91M
50.75%
-103.73M
70.31%
-107.29M
3.43%
investments in property plant and equipment
-1.93M
-
-4.88M
152.77%
-2.75M
43.58%
-1.79M
35.01%
-813K
54.53%
-731K
10.09%
-1.55M
112.31%
-1.25M
19.52%
-1.83M
46.36%
-1.82M
0.55%
acquisitions net
4.59M
-
1.79M
61.06%
20K
-
55K
175%
27K
50.91%
69K
155.56%
purchases of investments
-148.31M
-
-206.41M
39.17%
-175.73M
14.86%
-170.98M
2.70%
-171.18M
0.12%
-95.38M
44.28%
-220.32M
130.99%
-389.88M
76.96%
-188.97M
51.53%
-424.56M
124.68%
sales maturities of investments
109.23M
-
161.09M
47.48%
242.79M
50.72%
219.24M
9.70%
201.47M
8.10%
113.17M
43.83%
123.60M
9.21%
174.95M
41.54%
280.67M
60.43%
320.60M
14.23%
other investing activites
-1.79M
-
342K
119.13%
net cash used for investing activites
-41.01M
-
-50.19M
22.38%
68.91M
237.29%
46.47M
32.56%
29.82M
35.84%
17.08M
42.72%
-98.22M
675.05%
-216.16M
120.08%
89.94M
141.61%
-105.78M
217.61%
debt repayment
-2.96M
-
common stock issued
188.84M
-
13.95M
92.61%
51.02M
265.88%
29.02M
43.12%
16.25M
44.01%
170.79M
951.16%
269.89M
58.02%
4.08M
98.49%
218.46M
5,259.62%
common stock repurchased
dividends paid
other financing activites
1.17M
-
4.31M
268.15%
536K
87.57%
265K
50.56%
419K
58.11%
9K
97.85%
3.40M
37,633.33%
2.48M
27.00%
net cash used provided by financing activities
1.17M
-
193.15M
16,394.53%
14.48M
92.50%
51.29M
254.16%
29.44M
42.60%
16.26M
44.78%
171.23M
953.24%
272.37M
59.07%
4.08M
98.50%
218.46M
5,259.62%
effect of forex changes on cash
-5K
-
15K
400%
net change in cash
-141.38M
-
44.09M
131.18%
-29.65M
167.25%
-2.17M
92.67%
-15.98M
635.30%
-13.08M
18.15%
32.60M
349.30%
-4.69M
114.39%
-9.71M
106.99%
5.38M
155.44%
cash at beginning of period
169.40M
-
28.02M
83.46%
72.11M
157.34%
42.46M
41.11%
40.29M
5.12%
24.31M
39.66%
11.23M
53.80%
43.84M
290.28%
39.14M
10.71%
29.43M
24.82%
cash at end of period
28.02M
-
72.11M
157.34%
42.46M
41.11%
40.29M
5.12%
24.31M
39.66%
11.23M
53.80%
43.84M
290.28%
39.14M
10.71%
29.43M
24.82%
34.81M
18.30%
operating cash flow
-101.54M
-
-98.89M
2.61%
-113.04M
14.31%
-99.93M
11.59%
-75.23M
24.71%
-46.41M
38.31%
-40.40M
12.95%
-60.91M
50.75%
-103.73M
70.31%
-107.29M
3.43%
capital expenditure
-1.93M
-
-4.88M
152.77%
-2.75M
43.58%
-1.79M
35.01%
-813K
54.53%
-731K
10.09%
-1.55M
112.31%
-1.25M
19.52%
-1.83M
46.36%
-1.82M
0.55%
free cash flow
-103.47M
-
-103.76M
0.29%
-115.79M
11.59%
-101.72M
12.15%
-76.05M
25.24%
-47.15M
38.00%
-41.96M
11.01%
-62.16M
48.15%
-105.56M
69.83%
-109.11M
3.36%

All numbers in USD (except ratios and percentages)